Colleen M Cebulla, MD, PhD
College of Medicine
Molecular Biology and Cancer Genetics
Cancer, Melanoma, Retinoblastoma, Retinal Detachment, Inflammation, Down Syndrome, Endometrial Cancer
In addition to seeing patients, Dr. Cebulla is actively engaged in both basic and clinical. The focus of Dr. Cebulla's lab is translational research on retinal detachments and uveal melanoma. Also, a collaborative group with Dr. Cebulla, Dr. Mohammed Abdel-Rahman and Dr. Frederick Davidorf has identified that over 10% of patients with uveal melanoma have a heritable cancer syndrome. They are working hard to identify the genes responsible for increased cancer in the family and have identified a new cancer syndrome due to mutation in the BAP1 gene. They are currently involved in understanding factors which influence survival with metastatic disease and on targeted therapy for melanoma.